Voltage sensing domains (VSDs) couple changes in transmembrane electrical potential to 1 5 conformational changes that regulate ion conductance through a central channel. Positively 1 6 charged amino acids inside each sensor cooperatively respond to changes in voltage. Our 1 7 previous structure of a TPC1 channel captured the first example of a resting-state VSD in an 1 8 intact ion channel. To generate an activated state VSD in the same channel we removed the 1 9 luminal inhibitory Ca 2+ -binding site (Ca i 2+ ), that shifts voltage-dependent opening to more 2 0 negative voltage and activation at 0 mV. Cryo-EM reveals two coexisting structures of the VSD, 2 1
Introduction
). We employed saposin A nanoparticles (30) to reconstitute AtTPC1 DDE into a With a nominal resolution of 3.3 Å, the density map of AtTPC1 DDE is of high quality 1 0 9 ( Figure S4a ), allowing additional de-novo interpretation of the AtTPC1 N-terminal domain 1 1 0 (NTD), the S1-S2 linker, EF3-EF4 with an intact Ca a 2+ site, the upper vestibule of the pore, and depolarizing the transmembrane potential at low Ca 2+ . The fact that we observe intermediate
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N a t u r e 5 5 6 ( 7 6 9 9 ) : View of VSD2 in the membrane plane from the center of the channel looking outward, that illustrates the rotation and twisting of VSD2 helices S7, S8, S9, and S10. Connections to the pore domains omitted for clarity. S10 is highlighted in each state with a different color than the other helices. Gating charges R1-R3 (R537, R540, R543), and CT residue Y475 are shown. Left: resting-state AtTPC1 WT (red, PDBID 5DQQ), Center: AtTPC1 DDE state 1 (blue), and Right: AtTPC1 DDE state 2 (pink).
Figure 3. Activation of the Voltage-sensor.
Side views of a common slice perpendicular to the membrane surface of VSD2 in AtTPC1 WT resting-state (red, PDBID 5DQQ) and AtTPC1 DDE state 1 (blue) and state 2 (pink). S10 shown with gating charges R1-R3. The CT C position (black ball) is marked. Based on a structural alignment with respect to the pore helices S6-S7 of each structure. Figure 4 . Ion Permeation Pathway. a, b, Orthogonal side views through pore helices (a) S5-S6 (pore 1) and (b) S11-S12 (pore 2) of the channel homo-dimer overlaid with highresolution cryo-EM density (gray mesh). c, HOLE plot of pore radii along central channel coordinate of AtTPC1 DDE (red) and AtTPC1 WT (blue). d, Top down view through central pore. Gate residues Y305, L673, and F676 are shown. e-g, Side views through the selectivity filter in (e) pore 1, (f) pore 2, and (g) an overlay of pore 2 of AtTPC1 DDE (blue) and AtTPC1 WT (pink). Upper E605, D606 and lower S265, T263, T264, V628, M629, N631 selectivity filter residues are shown. Density for lipids (See Figure S7 ) and ions omitted for clarity. AtTPC1. X-ray and cryo-EM trials used AtTPC1 with deletion of residues 2-11(19). Antibody 5 3 7 generation employed full-length AtTPC1. AtTPC1 constructs were expressed and purified by 5 3 8 nickel affinity chromatography (NiNTA), thrombin cleavage, and size exclusion, as described were purified in the presence of 1mM TCEP during solubilization and binding to Nickel beads, 5 4 5 but then removed during wash and elution steps to prevent interference with MTSL-labeling.
4 6
AtTPC1 cysless has identical biochemical behavior to wild-type AtTPC1. purified from E. coli Rosetta-gami 2(DE3) cells essentially as described(30). Several colonies 5 4 9 from transformed cells were used to inoculate overnight 300 mL LB cultures containing 25 5 5 0 µg/mL chloramphenicol, 10 µg/mL tetracycline, and 15 µg/mL kanamycin at 37 ˚C. Overnight cultures were used to seed 6 L of Terrific Broth, grown to an absorbance value at 600 nm of 1.
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The temperature was adjusted to 20 ˚C 30 minutes prior to induction by 0.7 mM IPTG for 15 5 5 3 hours at 20 ˚C. Cells were harvested by centrifugation at 4,000x g for 10 minutes and minutes. The supernatant was then incubated at 70 ˚C for 10 minutes followed by centrifugation 5 5 8 at 26,000x g for 20 minutes to remove contaminant proteins. Imidazole pH 7.4 was then added to 5 5 9 20 mM and passed through two HisTrap FF crude 5mL columns equilibrated in Lysis Buffer was added with an exchange of the dialysis buffer and dialyzed at room temperature for 3 hours.
6 6
Uncleaved saposin A and free TEV were removed by passing the protein through a single purified and cleaved with TEV protease as described (41) Terrific Broth, grown at 37 ˚C until OD 600 of 1.3 and then induced with 1 mM IPTG for 3 hrs.
8 2
Cultures were harvested by centrifugation at 4,000x g for 10 minutes, resuspended in 50 mM NiNTA resin equilibrated with MSP Lysis Buffer was used in batch-binding for 1 hour at 4 ˚C.
8 7
Resin was then washed with MSP Lysis Buffer supplemented with: 1) 1% Triton X-100 -10 cleaved MSP was concentrated to 5 mg/mL using Millipore concentrators with 10 kDa molecular Antibodies. Monoclonal antibodies were expressed and purified from hybridoma culture 5 9 6 supernatants using standard methods in the Monoclonal Antibody Core Facility at OHSU (Dan 5 9 7
Cawley). 4B8 Fab fragment was generated by papain digestion 1/20 Papain:4B8 (w/w) at 30 ˚C Antibody fragments (Fabs) generated by phage display were expressed and purified 6 0 3 essentially as described (42) NaCl, concentrated with Millipore concentrators with 30 kDa molecular weight cutoff and stored 6 1 6 in aliquots at -80 ˚C. Typical yield from 1 L culture varied depending on Fab fragment and was 6 1 7 between 0.5 -3 mg. For cryo-EM studies Fab CAT06 was modified with H12 elbow variant as 6 1 8 described previously (43), resulting in the CAT06/H12 antibody fragment. Briefly, the H12 6 1 9 elbow variant exchanges heavy chain residues (112)SSASTK(117) (numbering according to 6 2 0 Kabat (44)) to (112)FNQI-K(117) with one position deleted from the sequence. Lipids. All lipids were prepared from thin films. Lipids were dissolved in chloroform, aliquoted restraint that R1-R3 must contact solvent, a polar side chain, or counter charge in the membrane. One position satisfied these criteria for each gating charge. 
